Myron Z. Holubiak, President and CEO at Citius Pharmaceuticals, Inc. (CTXR), bought 258,900 shares at $1.55 ($401K) on 2019-04-03, disclosed to the SEC on 2019-04-05.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.55 | 129,450 | $201K | 50.0% |
| 2 | $1.55 | 129,450 | $201K | 50.0% |
| Total | $1.55 avg | 258,900 | $401K | 100% |
| Filing → |
| CTXR | BUY | 2018-03-29 | $9K | — | Filing → |
| BIOS | SELL | 2014-06-18 | $40K | — | Filing → |
| BIOS | SELL | 2013-07-23 | $510K | — | Filing → |